| Primary |
| Paresis |
33.3% |
| Rheumatic Heart Disease |
33.3% |
| Tonsillitis |
33.3% |
|
| Neoplasm Malignant |
20.0% |
| Pallor |
20.0% |
| Rash |
20.0% |
| Skin Plaque |
20.0% |
| Tachycardia |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.3% |
| Pneumonia |
18.1% |
| Drug Use For Unknown Indication |
9.2% |
| Urosepsis |
6.7% |
| Pneumonia Pneumococcal |
5.2% |
| Renal Failure Acute |
4.7% |
| Urinary Tract Infection |
4.0% |
| Chronic Obstructive Pulmonary Disease |
3.7% |
| Brain Abscess |
2.0% |
| Hypertension |
2.0% |
| Pain |
2.0% |
| Bacterial Infection |
1.2% |
| Cellulitis |
1.2% |
| Endoscopy Gastrointestinal |
1.0% |
| Erysipelas |
1.0% |
| Escherichia Infection |
1.0% |
| Gangrene |
1.0% |
| Lyme Disease |
1.0% |
| Vomiting |
1.0% |
| Fungal Infection |
0.7% |
|
| Urosepsis |
30.2% |
| Respiratory Arrest |
15.1% |
| Diarrhoea |
5.7% |
| Jarisch-herxheimer Reaction |
5.7% |
| Pancytopenia |
5.7% |
| Thrombocytopenia |
5.7% |
| Drug Hypersensitivity |
3.8% |
| Po2 Decreased |
3.8% |
| Vomiting |
3.8% |
| Angioedema |
1.9% |
| Hepatic Fibrosis |
1.9% |
| Maternal Exposure During Delivery |
1.9% |
| Premature Baby |
1.9% |
| Rash |
1.9% |
| Renal Failure Acute |
1.9% |
| Tachypnoea |
1.9% |
| Toxic Epidermal Necrolysis |
1.9% |
| Toxicity To Various Agents |
1.9% |
| Urticaria |
1.9% |
| Vaginal Haemorrhage |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.9% |
| Alcohol Withdrawal Syndrome |
10.5% |
| Drug Use For Unknown Indication |
10.1% |
| Cardiac Failure |
8.6% |
| Pain |
7.5% |
| Diffuse Large B-cell Lymphoma |
5.5% |
| Pneumonia |
4.4% |
| Infection |
3.7% |
| Constipation |
3.3% |
| Pyrexia |
3.1% |
| Atrial Fibrillation |
2.6% |
| Renal Failure |
2.6% |
| Blood Cholesterol |
2.4% |
| Heart Rate |
2.4% |
| Osteomyelitis |
2.2% |
| Pneumonia Bacterial |
2.2% |
| Prophylaxis |
1.8% |
| Hypertension |
1.5% |
| Arthritis Bacterial |
1.3% |
| Chemotherapy |
1.3% |
|
| Vomiting |
17.1% |
| Renal Impairment |
9.8% |
| Pneumonitis |
8.5% |
| Drug Interaction |
6.1% |
| Renal Failure Acute |
6.1% |
| Rhabdomyolysis |
6.1% |
| Sepsis |
6.1% |
| Toxic Shock Syndrome |
4.9% |
| Acute Prerenal Failure |
3.7% |
| Intestinal Perforation |
3.7% |
| Malaise |
3.7% |
| Pulmonary Oedema |
3.7% |
| Tendon Rupture |
3.7% |
| Acute Hepatic Failure |
2.4% |
| Bone Marrow Failure |
2.4% |
| Cardio-respiratory Arrest Neonatal |
2.4% |
| Ill-defined Disorder |
2.4% |
| Liver Function Test Abnormal |
2.4% |
| Off Label Use |
2.4% |
| Paraesthesia |
2.4% |
|
| Interacting |
| Pneumonia |
33.3% |
| Product Used For Unknown Indication |
33.3% |
| Aortic Valve Replacement |
16.7% |
| Epilepsy |
16.7% |
|
| International Normalised Ratio Increased |
100.0% |
|
